Effect of long-term salmeterol therapy compared with As-needed albuterol use on airway hyperresponsiveness

Chest

Volumn 116, Issue 3, 1999, Pages 595-602

  Rosenthal, Richard R ^a,f   Busse, William W ^b   Kemp, James P ^c   Baker, James W ^d   Kalberg, Christopher ^e   Emmett, Amanda ^e   Rickard, Kathleen A ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^d Allergy Associates Research Center   (United States)

^e GLAXOSMITHKLINE   (United States)

^f NONE   (United States)

Author keywords

Asthma; Bronchial hyperresponsiveness; Methacholine challenge; Salmeterol

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; METHACHOLINE; METHAPHARM; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHITIS; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COMMON COLD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SORE THROAT; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032861839     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.3.595     Document Type: Article

References (19)

1. 1 National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and treatment of asthma. Bethesda, MD: National Institutes of Health, April 1997; Publication No. 97-4051
2. 2 Greening AP, Ind PW, Northfield M, et al. Added salmeterol vs higher-dose corticosteroid in asthma patients with symptoms on existing inhaled cortisteroid. Lancet 1994; 344:219-224
3. 3 Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153:1481-1488
4. 2-agonist salmeterol in mild to moderate asthmatic patients. Thorax 1993; 48:121-124
5. 5 Kalra S, Swystun VA, Bhagat R, et al. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 1996; 109:953-956
6. 6 Baghat R, Lalra S, Swystun VA, et al. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest 1996; 106:1235-1239
7. 2, adrenoreceptor antagonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327:1198-1203
8. 8 Chai H, Farr RS, Froelich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-327
9. 9 Derom EY, Pauwels RA, Van Der Straeten MEF. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J Allergy Clin Immunol 1992; 89:811-815
10. 10 Green SA, Turki J, Hall IP, et al. Implications of genetic variability of human β2-adrenergic receptor structure. Pulm Pharmacol 1995; 8:1-10
11. 11 D'Alonzo GE, Nathan RA, Henochowicz S, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271:1412-1416
12. 12 Pearlman D, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327:1420-1425
13. 13 Britton MC, Earnshaw JS, Palmer JBD. A 12-month comparison of salmeterol with salbutamol in asthmatic patients, Eur Respir J 1992; 5:1062-1067
14. 14 Sears MR, Taylor DR, Print CG, et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-1396
15. 15 Taylor DR, Sears MR, Herbison GP, et al. Regular inhaled β-agonist in asthma: effects on exacerbations and lung function. Thorax 1993; 48:134-138
16. 16 Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med 1996; 335:841-847
17. 17 Chapman KR, Kesten S, Szalal JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994; 343: 1379-1382
18. 2-agonists in the treatment of asthma [editorial]. N Engl J Med 1996; 335:886-888
19. 19 Global Initiatives for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, 1995; National Heart, Lung and Blood Institute Publication No. 95-3659